Arcadia Biosciences Welcomes Dr. Randy Shultz as Head of Research and Development

— Experienced R&D strategist brings deep expertise in advanced
breeding and gene editing technologies —

DAVIS, Calif.–(BUSINESS WIRE)–Arcadia
Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and
proven leader in agricultural innovation to improve the quality and
nutritional content of crops, announced today that Randy Shultz, Ph.D.
has joined the company’s leadership team as head of research and
development.

Shultz has nearly 20 years of experience in plant science and
agricultural biotechnology. The former global crop lead at Inari
Agriculture, he also served there as the director of R&D and senior
director of R&D strategy. Shultz was the first key scientific hire at
Inari, and played an instrumental role in building a scalable R&D
platform and developing a foundational intellectual property estate.
Before Inari, Shultz spent several years leading various scientific
production teams at Monsanto (now Bayer Crop Science), including their
Genome Editing Platform team.

“Throughout his career, Randy has established a reputation as a keen R&D
strategist, driving products through the pipeline from invention through
commercial planning,” said Raj Ketkar, Arcadia’s president and CEO.
“With his deep expertise in gene editing and new plant breeding
technologies, he will be exploring new partnerships and licensing
opportunities to expand our platform of tools to improve crops. We are
thrilled to have a science leader of Randy’s caliber as we build our
capabilities in cannabis and advance future innovations in our GoodWheat
portfolio of novel wheat attributes.”

“Arcadia is an innovative company with a strong technology foundation
and rich pipeline of novel products,” said Shultz. “I look forward to
working with Arcadia’s team of world-class scientists as we build the
next generation of products, bringing value to growers and downstream
partners.”

Shultz received his Ph.D. in functional genomics from North Carolina
State University and his B.S. degree from the University of Wisconsin,
Madison. He has authored over a dozen patents and publications.

About Arcadia Biosciences, Inc.

Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops
agricultural products that create added value for farmers, enhance human
health and improve the environmental sustainability of agriculture.
Arcadia’s nutrition traits and products are aimed at creating healthier
ingredients and whole foods with lower production costs. Arcadia’s
agronomic performance traits are aimed at making agricultural production
more economically efficient and environmentally sound. For more
information, visit www.arcadiabio.com.

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially, and reported results
should not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: the company’s
expectations of Randy Shultz’s potential contributions as an executive
on the leadership team; and the other risks set forth in the company’s
filings with the Securities and Exchange Commission from time to time,
including the risks set forth in the company’s Annual Report on Form
10-K for the year ended December 31, 2018. These forward-looking
statements speak only as of the date hereof, and Arcadia Biosciences,
Inc. disclaims any obligation to update these forward-looking statements.

Contacts

Jeff Bergau
[email protected]
+1-312-217-0419